A detailed history of Hrt Financial LP transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 3,836 shares of REGN stock, worth $2.69 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,836
Holding current value
$2.69 Million
% of portfolio
0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1024.09 - $1201.76 $3.93 Million - $4.61 Million
3,836 New
3,836 $4.03 Million
Q1 2024

May 13, 2024

BUY
$902.69 - $993.35 $4.51 Million - $4.96 Million
4,992 Added 82.29%
11,058 $10.6 Million
Q4 2023

Feb 09, 2024

SELL
$775.18 - $881.7 $3.56 Million - $4.05 Million
-4,590 Reduced 43.07%
6,066 $5.33 Million
Q3 2023

Nov 13, 2023

BUY
$692.45 - $844.37 $7.38 Million - $9 Million
10,656 New
10,656 $8.77 Million
Q4 2022

Feb 10, 2023

BUY
$705.89 - $766.39 $28.7 Million - $31.2 Million
40,648 New
40,648 $29.3 Million
Q4 2021

Feb 14, 2022

SELL
$543.48 - $670.97 $9.7 Million - $12 Million
-17,847 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$574.03 - $680.96 $2.24 Million - $2.65 Million
3,896 Added 27.93%
17,847 $10.8 Million
Q2 2021

Aug 16, 2021

SELL
$472.8 - $558.54 $830,236 - $980,796
-1,756 Reduced 11.18%
13,951 $7.79 Million
Q1 2021

May 17, 2021

BUY
$446.73 - $548.2 $7.02 Million - $8.61 Million
15,707 New
15,707 $7.43 Million
Q1 2020

May 15, 2020

SELL
$336.18 - $494.43 $1.28 Million - $1.89 Million
-3,815 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$274.13 - $376.51 $410,372 - $563,635
1,497 Added 64.58%
3,815 $1.43 Million
Q3 2019

Nov 14, 2019

BUY
$273.46 - $318.39 $633,880 - $738,028
2,318 New
2,318 $643,000
Q4 2018

Feb 15, 2019

SELL
$335.82 - $403.04 $677,684 - $813,334
-2,018 Closed
0 $0
Q3 2018

Nov 15, 2018

BUY
$351.14 - $408.51 $708,600 - $824,373
2,018 New
2,018 $815,000
Q2 2018

Aug 15, 2018

SELL
$284.6 - $344.99 $287,446 - $348,439
-1,010 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$315.82 - $393.78 $318,978 - $397,717
1,010 New
1,010 $347,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.